Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Healthc (Amst). 2016 Dec 5;5(3):105–111. doi: 10.1016/j.hjdsi.2016.11.001

Figure 1.

Figure 1

The projected prevalence of hepatitis C in Pennsylvania Medicaid categorized by diagnosed and undiagnosed cases in 2007–2050.

Note: After 2014, the projection of HCV prevalence was calculated under the coverage scenario of treating patients with F2–F4 fibrosis levels.